ArticleMolecular oncology2017

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.

Sofia Cotton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.